Arbutus Biopharma Corporation
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | $54.3M | $23.4M | $166.8M | $72.2M | $68.7M |
| Accounts Receivable | $402.0K | $273.0K | $1.0M | $1.9M | $117.0K |
| Inventory | — | — | — | — | — |
| Total Current Assets | $129.4M | $132.6M | $183.9M | $116.4M | $70.3M |
| Property, Plant & Equipment | $12.2M | $6.9M | $3.2M | $1.8M | $1.4M |
| Goodwill | $24.4M | $24.4M | $162.5M | $0 | — |
| Intangible Assets (Excl. Goodwill) | $58.6M | $99.4M | $352.6M | $0 | — |
| Total Assets | $237.2M | $275.9M | $712.3M | $118.2M | $71.7M |
| Liabilities | |||||
| Accounts Payable | $2.0M | $3.2M | $2.6M | $2.0M | $3.7M |
| Total Current Liabilities | $14.6M | $10.6M | $10.6M | $20.2M | $12.5M |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | $54.7M | $72.9M | $164.6M | $30.1M | $12.5M |
| Stockholders' Equity | |||||
| Retained Earnings | $-738.1M | $-652.7M | $-267.0M | $-205.9M | $-167.0M |
| Total Stockholders' Equity | $182.5M | $203.0M | $547.7M | $88.0M | $59.2M |